After the gap, begin tirzepatide at 2.5 mg weekly regardless of the prior semaglutide dose
Most patients report feeling satisfied with smaller meals within the first two weeks of starting therapy
Neurotherapeutics , 17(2), 672683
They make the page easier to audit
Tirzepatide, but not semaglutide, was capable of reducing aspartate aminotransferase (AST), alanine aminotransferase (ALT) and liver stiffness levels, and it was associated with a significantly higher rate of metabolic dysfunction-associated steatohepatitis (MASH) remission and a decrease of at least one stage of liver fibrosis
Instead, we vouch for medications backed by comprehensive clinical trials, ensuring quality and safety compliance that only branded, FDA-approved options offer